PeptidePedia The community reference

Contributions of COA_Colwyn

User contributions·59 logged edits·page 1 of 1

Contributions by COA_Colwyn, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 13,744 edits includes activity predating the current log.

  1. 09:46, 15 Jul 2026 (diff | hist) Chinese Peptide Company 12,627 ±0 m tag [citation needed]
  2. 02:58, 10 Jul 2026 (diff | hist) Zhuhai Kerui Biotechnology 12,118 ±0 fix unit
  3. 17:04, 28 Jun 2026 (diff | hist) Shanghai ERP Biotechnology 11,702 ±0 tag [citation needed]
  4. 21:49, 21 Jun 2026 (diff | hist) GL Biochem (Shanghai) 13,879 ±0 m state the assay for the reference interval
  5. 00:09, 14 Jun 2026 (diff | hist) Peptide stability table 6,886 ±0 m expand §The table
  6. 08:50, 7 Jun 2026 (diff | hist) Shanghai ERP Biotechnology 11,702 ±0 convert prose to table for comparability
  7. 03:09, 2 Jun 2026 (diff | hist) Zhuhai Kerui Biotechnology 12,118 ±0 de-orphan
  8. 05:43, 22 May 2026 (diff | hist) Lyophilisation 28,679 ±0 convert list to prose
  9. 13:45, 13 May 2026 (diff | hist) Zhuhai Kerui Biotechnology 12,118 ±0 convert list to prose
  10. 12:47, 13 May 2026 (diff | hist) Talk:Sangon Biotech 537 +344 /* Comparing documentation within one organisation */ new section
  11. 22:22, 30 Mar 2026 (diff | hist) Xi'an Mokemei Biotechnology 12,475 ±0 m fix unit
  12. 23:19, 24 Mar 2026 (diff | hist) Hubei Jianxiang Bioscience 12,122 ±0 fix category — parent was wrong
  13. 08:16, 10 Mar 2026 (diff | hist) Syringe dead space 20,340 ±0 correct molar mass
  14. 07:18, 10 Mar 2026 (diff | hist) Hunan Aslsen Technology 12,103 ±0 attribute claim in-text
  15. 19:41, 8 Mar 2026 (diff | hist) Tianjin Finder Chemical 11,889 ±0 add {{refimprove}}
  16. 08:24, 5 Feb 2026 (diff | hist) Cold chain 27,220 ±0 m add see also
  17. 12:06, 16 Jan 2026 (diff | hist) Chinese Peptide Company 12,627 ±0 m rv restoration of unsourced claim
  18. 01:18, 14 Dec 2025 (diff | hist) Wuhan Wansheng Biotechnology 12,729 ±0 m lead should summarise the body, not add to it
  19. 05:32, 6 Dec 2025 (diff | hist) Xi'an Mokemei Biotechnology 11,359 +798 m reorder sections to follow the class template
  20. 00:11, 1 Dec 2025 (diff | hist) Chinese Peptide Company 12,627 ±0 update infobox
  21. 19:09, 27 Nov 2025 (diff | hist) Glucagon-like peptide-1 12,294 ±0 m lead should summarise the body, not add to it
  22. 13:28, 10 Nov 2025 (diff | hist) Tianjin Finder Chemical 11,703 ±0 m ce per MOS
  23. 23:20, 2 Nov 2025 (diff | hist) Shanghai ERP Biotechnology 7,202 +617 m replace primary source with the review
  24. 03:39, 29 Oct 2025 (diff | hist) WuXi TIDES 13,083 ±0 m promote subsection to section
  25. 23:56, 17 Oct 2025 (diff | hist) Shanghai ERP Biotechnology 6,585 +27 m consistent en dashes in ranges
  26. 03:46, 30 Sep 2025 (diff | hist) Guangzhou JEEP Biotechnology 12,647 +680 m attribute range as a review estimate per talk
  27. 09:22, 18 Sep 2025 (diff | hist) Talk:WuXi TIDES 959 +286 /* Is "agreement with the certificate" worth reporting? */ reply
  28. 23:55, 29 Aug 2025 (diff | hist) Bachem Holding (Suzhou) 11,425 +798 attribute range as a review estimate per talk
  29. 23:03, 19 Aug 2025 (diff | hist) Shanghai ERP Biotechnology 4,147 ±0 split section
  30. 14:35, 7 Aug 2025 (diff | hist) Shanghai ERP Biotechnology 3,955 ±0 undo good-faith edit: the source does not say this
  31. 02:56, 18 Jul 2025 (diff | hist) Sangon Biotech 7,862 ±0 m add citation
  32. 10:14, 17 Jul 2025 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 1,170 +60 /* Documentation gradient across the catalogue */ reply
  33. 11:20, 14 Jul 2025 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 537 +267 /* Documentation gradient across the catalogue */ new section
  34. 23:45, 21 Jun 2025 (diff | hist) Bachem Holding (Suzhou) 10,130 ±0 fix hyphenation per PP:MOS
  35. 05:50, 21 Jun 2025 (diff | hist) Shanghai Wibson Biotechnology 7,362 +444 add hatnote
  36. 15:19, 2 Jun 2025 (diff | hist) Reconstitution calculator 6,980 ±0 expand §Worked examples
  37. 21:30, 25 May 2025 (diff | hist) Guangzhou JEEP Biotechnology 10,736 +271 m fix category — parent was wrong
  38. 14:49, 15 May 2025 (diff | hist) WuXi TIDES 9,852 ±0 British spelling per PP:MOS
  39. 05:46, 8 May 2025 (diff | hist) Chinese Peptide Company 10,395 ±0 rv addition of price information per PP:VN
  40. 13:37, 1 May 2025 (diff | hist) Tianjin Finder Chemical 6,782 ±0 m link to the policy rather than restating it
  41. 05:26, 31 Mar 2025 (diff | hist) Xi'an Mokemei Biotechnology 2,368 +38 reorder sections to follow the class template
  42. 00:10, 24 Mar 2025 (diff | hist) Xi'an Mokemei Biotechnology 2,179 ±0 m split overlong sentence
  43. 09:00, 19 Mar 2025 (diff | hist) Xi'an Mokemei Biotechnology 2,179 +2,179 N start article
  44. 22:09, 3 Mar 2025 (diff | hist) Shanghai Wibson Biotechnology 4,104 +182 tag [citation needed]
  45. 08:29, 2 Mar 2025 (diff | hist) WuXi TIDES 8,673 +320 undo good-faith edit: the source does not say this
  46. 19:24, 8 Feb 2025 (diff | hist) Bachem Holding (Suzhou) 6,584 ±0 m add figure
  47. 01:59, 4 Feb 2025 (diff | hist) Hunan Aslsen Technology 6,139 +144 fix hyphenation per PP:MOS
  48. 18:57, 25 Jan 2025 (diff | hist) GL Biochem (Shanghai) 9,123 +489 lead should summarise the body, not add to it
  49. 19:26, 11 Dec 2024 (diff | hist) Tianjin Finder Chemical 3,766 ±0 m add hatnote
  50. 19:21, 25 Nov 2024 (diff | hist) Shanghai Sigma-Audley New Material Technology 2,703 ±0 convert list to prose
  51. 01:30, 20 Nov 2024 (diff | hist) Tianjin Finder Chemical 2,727 ±0 fix unit
  52. 00:08, 14 Nov 2024 (diff | hist) Lyophilisation 10,221 +869 m move unsourced paragraph to talk
  53. 18:41, 25 Oct 2024 (diff | hist) WuXi TIDES 5,373 +808 ce
  54. 08:02, 24 Oct 2024 (diff | hist) Bachem Holding (Suzhou) 2,097 ±0 promote subsection to section
  55. 09:18, 8 Sep 2024 (diff | hist) Chinese Peptide Company 2,669 ±0 add citation
  56. 21:29, 3 Sep 2024 (diff | hist) Vial 6,759 ±0 add table
  57. 23:16, 6 Aug 2024 (diff | hist) Chinese Peptide Company 2,212 ±0 m cite the trial publication rather than the press release
  58. 12:42, 11 Jul 2024 (diff | hist) Enteroendocrine L cell 1,903 ±0 consistent en dashes in ranges
  59. 13:23, 9 Jul 2024 (diff | hist) Guangzhou JEEP Biotechnology 1,725 +1,725 N create article